Lupus anticoagulant is frequent in patients with Covid-19

被引：1
作者：
Harzallah, Ines [1 ]
Debliquis, Agathe [1 ]
Drenou, Bernard [2 ]
机构：
[1] Grp Hosp Reg Mulhouse Sud Alsace, Lab Hematol, 20 Rue Dr Laennec, F-68070 Mulhouse, France
[2] Grp Hosp Reg Mulhouse Sud Alsace, Dept Hematol, Mulhouse, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2020年 / 18卷 / 08期
关键词：
D O I：
10.1111/jth.14867
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2064 / 2065
页数：2
相关论文
共 50 条
  • [31] Lupus anticoagulant is an independent risk factor for non-thrombotic in-hospital mortality in COVID-19 patients
    Constans, Mireia
    Santiago, Raquel
    Jimenez, Lidia
    Motllo, Cristina
    Lopez, Rosario
    Trape, Jaume
    Carlos Reverter, J.
    Altes, Albert
    THROMBOSIS RESEARCH, 2021, 208 : 99 - 105
  • [32] Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis
    Kow, Chia Siang
    Zaihan, Abdullah Faiz
    Hasan, Syed Shahzad
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (12)
  • [33] Patients with lupus with COVID-19: University of Michigan experience
    Wallace, Beth
    Washer, Laraine
    Marder, Wendy
    Kahlenberg, J. Michelle
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (03)
  • [34] Role of lupus anticoagulant and von Willebrand factor in chronic reactive endotheliitis in COVID-19
    Lopez Reboiro, Manuel Lorenzo
    Suarez Fuentetaja, Rebeca
    Gutierrez Lopez, Raquel
    Ares Castro-Conde, Beatriz
    Sardina Gonzalez, Cristina
    Navarro Menendez, Ines
    Pereyra Barrionuevo, Marco Francisco
    Alves Perez, M. Teresa
    Lopez Castro, Jose
    JOURNAL OF INFECTION, 2021, 82 (06) : E27 - E28
  • [35] Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive (vol 6, e12809, 2022)
    Spruit, M. A.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (07)
  • [36] Anticoagulant Treatment Regimens in Patients with Covid-19: A Meta-Analysis
    Jorda, Anselm
    Siller-Matula, Jolanta M.
    Zeitlinger, Markus
    Jilma, Bernd
    Gelbenegger, Georg
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (03) : 614 - 623
  • [37] Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
    Javid, Amir
    Kazemi, Reza
    Dehghani, Mehdi
    Samani, Hossein Bahrami
    UROLOGY CASE REPORTS, 2021, 36
  • [38] COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?
    Aubignat, M.
    Godefroy, O.
    REVUE NEUROLOGIQUE, 2020, 176 (06) : 505 - 506
  • [39] COVID-19: coagulation disorders and anticoagulant treatment in patients hospitalised in ICU
    Pluta, Jan
    Cieniewicz, Agnieszka
    Trzebicki, Janusz
    ANAESTHESIOLOGY INTENSIVE THERAPY, 2021, 53 (02) : 153 - 161
  • [40] Lupus anticoagulants as a prospective independent predictor in COVID-19 patients
    Kim, Hyunji
    Chu, Daehyun
    Kim, Miyoung
    Cho, Young-uk
    Park, Chan-jeoung
    Bae, Seongman
    Kim, Min Jae
    Chong, Yong Pil
    Jang, Seongsoo
    Kim, Sung-Han
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 (02) : 163 - 169
12345